Evidence map›Paper›PMID 35481474›Full record

ArticleAnalytical methods : advancing methods and applications2022

Simple manipulation of enzyme-linked immunosorbent assay (ELISA) using an automated microfluidic interface.

Yosita Panraksa, Ilhoon Jang, Cody S Carrell, Anita G Amin, Orawon Chailapakul, Delphi Chatterjee, Charles S Henry

Open access · greenAbstract read
In one paragraph

Article in Analytical methods : advancing methods and applications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Yosita PanraksaMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, 1682 Campus Delivery, Fort Collins, CO, 80523, USA. Delphi.Chatterjee@colostate.edu.
Ilhoon JangDepartment of Chemistry, Colorado State University, CO, USA, 80523. Chuck.Henry@colostate.edu.ORCID 0000-0003-1028-1398
Cody S CarrellDepartment of Chemistry, Colorado State University, CO, USA, 80523. Chuck.Henry@colostate.edu.
Anita G AminMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, 1682 Campus Delivery, Fort Collins, CO, 80523, USA. Delphi.Chatterjee@colostate.edu.
Orawon ChailapakulElectrochemistry and Optical Spectroscopy Center of Excellence (EOSCE), Department of Chemistry, Faculty of Science, Chulalongkorn University, 254 Phayathai Road, Patumwan, Bangkok, 10330, Thailand. Corawon@chula.ac.th.
Delphi ChatterjeeMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, 1682 Campus Delivery, Fort Collins, CO, 80523, USA. Delphi.Chatterjee@colostate.edu.
Charles S HenryDepartment of Chemistry, Colorado State University, CO, USA, 80523. Chuck.Henry@colostate.edu.ORCID 0000-0002-8671-7728
Chulalongkorn University · THColorado State University · USHanyang University · KR

Funding

Validation of urine/serum LAM in HIV/nonHIV TB suspects and POC Test DevelopmentR01AI132680 · NIAID · COLORADO STATE UNIVERSITY · PI CHATTERJEE, DELPHI · 2018 to 2021
$2.3M
NIAID NIH HHS R01 AI132680
6 · The paper itself

Abstract

Among lateral flow immunoassay (LFIA) platforms, enzyme-based LFIAs provide signal amplification to improve sensitivity. However, most enzyme-based LFIAs require multiple timed steps, complicating their utility in point-of-care testing (POCT). Here, we report a microfluidic interface for LFIAs that automates sample, buffer, and reagent addition, greatly simplifying operation while achieving the high analytical stringency associated with more complex assays. The microfluidic interface also maintains the low cost and small footprint of standard LFIAs. The platform is fabricated from a combination of polyester film, double-sided adhesive tape, and nitrocellulose, and fits in the palm of your hand. All reagents are dried on the nitrocellulose to facilitate sequential reagent delivery, and the sample is used as the wash buffer to minimize steps. After the sample addition, a user simply waits 15 min for a colorimetric result. This manuscript discusses the development and optimization of the channel geometry to achieve a simple step enzyme amplified immunoassay. As a proof-of-concept target, we selected lipoarabinomannan (LAM), a WHO identified urinary biomarker of active tuberculosis, to demonstrate the device feasibility and reliability. The results revealed that the device successfully detected LAM in phosphate buffer (PBS) as well as spiked urine samples within 15 min after sample loading. The minimum concentration of color change was achieved at 25 ng mL

Indexed as

MicrofluidicsCollodionEnzyme-Linked Immunosorbent AssayImmunoassayReproducibility of ResultsCollodion

Identifiers

PMID35481474
PMCPMC9119197
OpenAlexW4225110316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.